A major expansion at Arkansas Children's Hospital is creating a dedicated space where researchers can test new treatments and therapies directly with children, potentially speeding up the discovery of life-changing medical breakthroughs. Thanks to a $371 million investment, the Arkansas Children's Research Institute (ACRI) is building an expanded Pediatric Clinical Research Unit (PCRU) that will open in mid-2026 on the second floor of the Champions Pavilion, a new outpatient care facility in Little Rock .

The current PCRU occupies just 4,000 square feet with two private rooms and four open bays, limiting how many children can participate in research studies at any given time. The new facility will be dramatically larger and more specialized, designed as what researchers call a "one-stop shop" for clinical trials and research visits .

What Makes This New Research Space Different?

The expanded PCRU represents a significant leap forward in how pediatric research can be conducted. Instead of patients moving between different departments for blood draws, lab work, pharmacy consultations, and other procedures, everything will be centralized in one dedicated floor. This matters because it reduces stress on children and families while allowing researchers to conduct more complex studies without logistical barriers .

The new facility will include specialized treatment and observation rooms that don't exist in the current space. Two rooms will feature one-way mirrors for neurocognitive testing and behavioral assessments related to conditions such as autism, allowing researchers to observe participants without creating anxiety or distraction. Additionally, four negative-pressure rooms will be equipped with advanced infection-control systems, designed to prevent air from escaping and protect both patients and staff during studies involving infectious diseases or investigational medicines that alter immune response .

How Will the Expanded PCRU Improve Research Capacity?

• Physical Space: The new PCRU will occupy 14,000 square feet, more than triple the current 4,000-square-foot footprint, allowing researchers to conduct more studies simultaneously.
• Private Treatment Rooms: The facility will include 16 private treatment rooms compared to the current two, providing greater flexibility in scheduling and patient privacy during research visits.
• Integrated Services: All essential services including phlebotomy (blood drawing), laboratory testing, pharmacy services, and a kitchen will be located in one place, eliminating the need for patients to travel between departments.
• Specialized Equipment: Four negative-pressure rooms will enable researchers to perform procedures like pulmonary function testing for conditions such as Cystic Fibrosis and Duchenne Muscular Dystrophy without moving patients to separate facilities.
• Research Support: Additional workspaces for team members and research investigators, plus expanded storage for equipment and supplies, will support a growing number of studies from diverse funding sources.

The PCRU currently houses studies funded by the National Institutes of Health (NIH), other federal agencies, and an increasing number of industry-sponsored collaborative studies from biotech and pharmaceutical companies committed to advancing pediatric health care .

"The Arkansas Children's vision statement has been updated to include the word 'discovered,' reflecting our commitment to innovation and advanced care. It now states, 'Unprecedented child health. Defined, discovered, delivered.' This expanded PCRU embodies that spirit of discovery," explained Megan Gorski, director of clinical research operations for ACRI.

Megan Gorski, Director of Clinical Research Operations, Arkansas Children's Research Institute

Gorski emphasized that every study conducted in the PCRU has the potential to transform pediatric health care not only in Arkansas but globally, given the reach and impact of the research conducted there .

Why Does This Matter for Children's Health?

Clinical research units like the PCRU are where promising laboratory discoveries become real treatments that children can benefit from. By creating a modern, child-friendly space that can accommodate more research participants, Arkansas Children's is removing barriers that have historically limited how many children can access cutting-edge clinical trials. This expanded capacity means more children will have opportunities to participate in studies that could lead to new therapies for serious conditions .

The specialized rooms for neurocognitive testing and infection-control procedures represent another critical advancement. Researchers studying autism, behavioral disorders, and infectious diseases will be able to conduct more sophisticated assessments and procedures without exposing patients to unnecessary risks or requiring them to move between facilities. For children with conditions like Cystic Fibrosis or Duchenne Muscular Dystrophy, having pulmonary function testing available on-site means fewer appointments and less disruption to their lives .

The expansion also reflects a broader commitment to pediatric research innovation. Arkansas Children's has been ranked by U.S. News and World Report in seven specialties for 2025-2026, and this new facility positions the organization to continue advancing the field of pediatric medicine through rigorous, ethical research that follows strict safety guidelines to protect participants and their families .

When the Champions Pavilion opens in mid-2026, the new PCRU will represent one of the most advanced pediatric research facilities in the country, designed from the ground up to make participation easier for children and families while enabling researchers to conduct the studies that could define the next generation of pediatric health care.